Current Treatment Options in Gastroenterology

, Volume 15, Issue 3, pp 333–348 | Cite as

Endoscopic Palliation of Pancreatic Cancer

  • Vishal B. Gohil
  • Jason B. KlapmanEmail author
Pancreas (V Chandrasekhara, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Pancreas

Opinion statement

Pancreas cancer is a fourth-leading cause of cancer death in the USA and its incidence is rising as the population is aging. The majority of patients present at an advanced stage due to the silent nature of the disease and treatment have focused more on palliation than curative intent. Gastroenterologists have become integral in the multidisciplinary care of these patients with a focus on providing endoscopic palliation of pancreas cancer. The three most common areas that gastroenterologists palliate endoscopically are biliary obstruction, cancer-related pain, and gastric outlet obstruction. To palliate biliary obstruction, the procedure of choice is to perform endoscopic retrograde cholangiopancreatography (ERCP) with biliary stent placement. We tend to place covered self-expandable metal stents (SEMS) due to their longer patency and removability unless the patient has resectable disease. Pancreas cancer pain is a result of tumor infiltration of the celiac plexus and can be severe and poorly responsive to narcotics. To improve pain control, neurolysis of the celiac plexus has been performed for decades. Since 1996, neurolysis of the celiac area has been performed endoscopically by Endoscopic Ultrasound-Guided Celiac Plexus Neurolysis. This has proven to be as safe and effective as traditional non-endoscopic methods and has allowed the patients to decrease their narcotic use and improve their pain control. This should be done early on in the course of the disease to have maximal effect. Gastric outlet obstruction (GOO) occurs in approximately 15–20% of patients with pancreas cancer. Endoscopic palliation of GOO can be performed by placing uncovered metal enteral stents across the obstruction. This procedure has proven to be very effective in patients who have a short life expectancy (less than two to 6 months) while surgical bypass should be considered for patients with longer life expectancies because it offers better long-term symptom relief. This chapter will review the current literature, latest advancements, and optimal techniques for endoscopic palliation of pancreatic cancer.


Gastrojejunostomy (GJ) Malignant gastric outlet obstruction (GOO) Biliary obstruction Celiac plexus neurolysis Stent Endoscopic ultrasound Pancreas cancer 


Compliance with Ethical Standards

Conflict of Interest

Vishal B. Gohil declares that he has no conflict of interest. Jason B. Klapman declares that he has no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.


Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    American Cancer Society: Cancer facts and figures 2017. Atlanta, Ga. American Cancer Society. 2017.Google Scholar
  2. 2.
    Barkin JS, Goldstein JA. Diagnostic approach to pancreatic cancer. Gastroenterol Clin N Am. 1999;28(3):709–22. xiCrossRefGoogle Scholar
  3. 3.
    Kozarek RA. Endoscopy in the management of malignant obstructive jaundice. Gastrointest Endosc Clin N Am. 1996;6(1):153–76.PubMedGoogle Scholar
  4. 4.
    Levy MJ, Baron TH, Gostout CJ, Petersen BT, Farnell MB. Palliation of malignant extrahepatic biliary obstruction with plastic versus expandable metal stents: an evidence-based approach. Clin Gastroenterol Hepatol. 2004;2(4):273–85.PubMedCrossRefGoogle Scholar
  5. 5.
    Moss AC, Morris E, Leyden J, MacMathuna P. Malignant distal biliary obstruction: a systematic review and meta-analysis of endoscopic and surgical bypass results. Cancer Treat Rev. 2007;33(2):213–21. doi: 10.1016/j.ctrv.2006.10.006.PubMedCrossRefGoogle Scholar
  6. 6.
    Ferreira LE, Baron TH. Endoscopic stenting for palliation of malignant biliary obstruction. Expert Rev Med Devices. 2010;7(5):681–91. doi: 10.1586/erd.10.36.PubMedCrossRefGoogle Scholar
  7. 7.
    Pfau PR, Pleskow DK, Banerjee S, Barth BA, Bhat YM, Desilets DJ, et al. Pancreatic and biliary stents. Gastrointest Endosc. 2013;77(3):319–27. doi: 10.1016/j.gie.2012.09.026.PubMedCrossRefGoogle Scholar
  8. 8.
    Cipolletta L, Rotondano G, Marmo R, Bianco MA. Endoscopic palliation of malignant obstructive jaundice: an evidence-based review. Dig Liver Dis. 2007;39(4):375–88. doi: 10.1016/j.dld.2006.12.016.PubMedCrossRefGoogle Scholar
  9. 9.
    Loew BJ, Howell DA, Sanders MK, Desilets DJ, Kortan PP, May GR, et al. Comparative performance of uncoated, self-expanding metal biliary stents of different designs in 2 diameters: final results of an international multicenter, randomized, controlled trial. Gastrointest Endosc. 2009;70(3):445–53. doi: 10.1016/j.gie.2008.11.018.PubMedCrossRefGoogle Scholar
  10. 10.
    Dumonceau JM, Tringali A, Blero D, Deviere J, Laugiers R, Heresbach D, et al. Biliary stenting: indications, choice of stents and results: European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline. Endoscopy. 2012;44(3):277–98. doi: 10.1055/s-0031-1291633.PubMedCrossRefGoogle Scholar
  11. 11.
    Moy BT, Birk JW. An update to hepatobiliary stents. J Clin Transl Hepatol. 2015;3(1):67–77. doi: 10.14218/jcth.2015.00040.PubMedPubMedCentralCrossRefGoogle Scholar
  12. 12.
    Sejpal D. Advancements in biliary stenting. J Clin Gastroenterol. 2012;46(3):191–6. doi: 10.1097/MCG.0b013e3182410367.PubMedCrossRefGoogle Scholar
  13. 13.
    Yoon WJ, Ryu JK, Yang KY, Paik WH, Lee JK, Woo SM, et al. A comparison of metal and plastic stents for the relief of jaundice in unresectable malignant biliary obstruction in Korea: an emphasis on cost-effectiveness in a country with a low ERCP cost. Gastrointest Endosc. 2009;70(2):284–9. doi: 10.1016/j.gie.2008.12.241.PubMedCrossRefGoogle Scholar
  14. 14.
    Davids PH, Groen AK, Rauws EA, Tytgat GN, Huibregtse K. Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet. 1992;340(8834–8835):1488–92.CrossRefPubMedGoogle Scholar
  15. 15.
    Kaassis M, Boyer J, Dumas R, Ponchon T, Coumaros D, Delcenserie R, et al. Plastic or metal stents for malignant stricture of the common bile duct? Results of a randomized prospective study. Gastrointest Endosc. 2003;57(2):178–82. doi: 10.1067/mge.2003.66.PubMedCrossRefGoogle Scholar
  16. 16.
    Soderlund C, Linder S. Covered metal versus plastic stents for malignant common bile duct stenosis: a prospective, randomized, controlled trial. Gastrointest Endosc. 2006;63(7):986–95. doi: 10.1016/j.gie.2005.11.052.PubMedCrossRefGoogle Scholar
  17. 17.
    Speer AG, Cotton PB, MacRae KD. Endoscopic management of malignant biliary obstruction: stents of 10 French gauge are preferable to stents of 8 French gauge. Gastrointest Endosc. 1988;34(5):412–7.PubMedCrossRefGoogle Scholar
  18. 18.
    Kadakia SC, Starnes E. Comparison of 10 French gauge stent with 11.5 French gauge stent in patients with biliary tract diseases. Gastrointest Endosc. 1992;38(4):454–9.PubMedCrossRefGoogle Scholar
  19. 19.
    Kullman E, Frozanpor F, Soderlund C, Linder S, Sandstrom P, Lindhoff-Larsson A, et al. Covered versus uncovered self-expandable nitinol stents in the palliative treatment of malignant distal biliary obstruction: results from a randomized, multicenter study. Gastrointest Endosc. 2010;72(5):915–23. doi: 10.1016/j.gie.2010.07.036.PubMedCrossRefGoogle Scholar
  20. 20.
    Kitano M, Yamashita Y, Tanaka K, Konishi H, Yazumi S, Nakai Y, et al. Covered self-expandable metal stents with an anti-migration system improve patency duration without increased complications compared with uncovered stents for distal biliary obstruction caused by pancreatic carcinoma: a randomized multicenter trial. Am J Gastroenterol. 2013;108(11):1713–22. doi: 10.1038/ajg.2013.305.PubMedCrossRefGoogle Scholar
  21. 21.
    Telford JJ, Carr-Locke DL, Baron TH, Poneros JM, Bounds BC, Kelsey PB, et al. A randomized trial comparing uncovered and partially covered self-expandable metal stents in the palliation of distal malignant biliary obstruction. Gastrointest Endosc. 2010;72(5):907–14. doi: 10.1016/j.gie.2010.08.021.PubMedCrossRefGoogle Scholar
  22. 22.
    Saleem A, Leggett CL, Murad MH, Baron TH. Meta-analysis of randomized trials comparing the patency of covered and uncovered self-expandable metal stents for palliation of distal malignant bile duct obstruction. Gastrointest Endosc. 2011;74(2):321–7.e1-3. doi: 10.1016/j.gie.2011.03.1249.PubMedCrossRefGoogle Scholar
  23. 23.
    Almadi MA, Barkun AN, Martel M. No benefit of covered vs uncovered self-expandable metal stents in patients with malignant distal biliary obstruction: a meta-analysis. Clin Gastroenterol Hepatol. 2013;11(1):27–37.e1. doi: 10.1016/j.cgh.2012.10.019.PubMedCrossRefGoogle Scholar
  24. 24.
    Moss AC, Morris E, Leyden J, MacMathuna P. Do the benefits of metal stents justify the costs? A systematic review and meta-analysis of trials comparing endoscopic stents for malignant biliary obstruction. Eur J Gastroenterol Hepatol. 2007;19(12):1119–24. doi: 10.1097/MEG.0b013e3282f16206.PubMedCrossRefGoogle Scholar
  25. 25.
    Committee ASoP, Chandrasekhara V, Khashab MA, Muthusamy VR, Acosta RD, Agrawal D, et al. Adverse events associated with ERCP. Gastrointest Endosc. 2017;85(1):32–47. doi: 10.1016/j.gie.2016.06.051.CrossRefGoogle Scholar
  26. 26.
    Yang KY, Ryu JK, Seo JK, Woo SM, Park JK, Kim YT, et al. A comparison of the Niti-D biliary uncovered stent and the uncovered Wallstent in malignant biliary obstruction. Gastrointest Endosc. 2009;70(1):45–51. doi: 10.1016/j.gie.2008.10.029.PubMedCrossRefGoogle Scholar
  27. 27.
    Fumex F, Coumaros D, Napoleon B, Barthet M, Laugier R, Yzet T, et al. Similar performance but higher cholecystitis rate with covered biliary stents: results from a prospective multicenter evaluation. Endoscopy. 2006;38(8):787–92. doi: 10.1055/s-2006-944515.PubMedCrossRefGoogle Scholar
  28. 28.
    • Nakai Y, Isayama H, Kawakubo K, Kogure H, Hamada T, Togawa O, et al. Metallic stent with high axial force as a risk factor for cholecystitis in distal malignant biliary obstruction. J Gastroenterol Hepatol. 2014;29(7):1557–62. doi: 10.1111/jgh.12582. Keep in mind risk factor of developing acute cholecystitis while placing SEMS- neoplastic involvement of cystic duct and SEMS with high axial force.PubMedCrossRefGoogle Scholar
  29. 29.
    Artifon EL, Sakai P, Ishioka S, Marques SB, Lino AS, Cunha JE, et al. Endoscopic sphincterotomy before deployment of covered metal stent is associated with greater complication rate: a prospective randomized control trial. J Clin Gastroenterol. 2008;42(7):815–9. doi: 10.1097/MCG.0b013e31803dcd8a.PubMedCrossRefGoogle Scholar
  30. 30.
    Banerjee N, Hilden K, Baron TH, Adler DG. Endoscopic biliary sphincterotomy is not required for transpapillary SEMS placement for biliary obstruction. Dig Dis Sci. 2011;56(2):591–5. doi: 10.1007/s10620-010-1317-z.PubMedCrossRefGoogle Scholar
  31. 31.
    Cote GA, Kumar N, Ansstas M, Edmundowicz SA, Jonnalagadda S, Mullady DK, et al. Risk of post-ERCP pancreatitis with placement of self-expandable metallic stents. Gastrointest Endosc. 2010;72(4):748–54. doi: 10.1016/j.gie.2010.05.023.PubMedCrossRefGoogle Scholar
  32. 32.
    Wong GY, Schroeder DR, Carns PE, Wilson JL, Martin DP, Kinney MO, et al. Effect of neurolytic celiac plexus block on pain relief, quality of life, and survival in patients with unresectable pancreatic cancer: a randomized controlled trial. JAMA. 2004;291(9):1092–9. doi: 10.1001/jama.291.9.1092.PubMedCrossRefGoogle Scholar
  33. 33.
    NCCN. NCCN guidelines for pancreas adenocarcinoma. 2017.Google Scholar
  34. 34.
    Wiersema MJ, Wiersema LM. Endosonography-guided celiac plexus neurolysis. Gastrointest Endosc. 1996;44(6):656–62.PubMedCrossRefGoogle Scholar
  35. 35.
    Luz LP, Al-Haddad MA, DeWitt JA. EUS-guided celiac plexus interventions in pancreatic cancer pain: an update and controversies for the endosonographer. Endoscopic Ultrasound. 2014;3(4):213–20. doi: 10.4103/2303-9027.144515.PubMedPubMedCentralCrossRefGoogle Scholar
  36. 36.
    Bang JY, Hasan MK, Sutton B, Holt BA, Navaneethan U, Hawes R, et al. Intraprocedural increase in heart rate during EUS-guided celiac plexus neurolysis: clinically relevant or just a physiologic change? Gastrointest Endosc. 2016;84(5):773–9.e3. doi: 10.1016/j.gie.2016.03.1496.PubMedCrossRefGoogle Scholar
  37. 37.
    Yan BM, Myers RP. Neurolytic celiac plexus block for pain control in unresectable pancreatic cancer. Am J Gastroenterol. 2007;102(2):430–8. doi: 10.1111/j.1572-0241.2006.00967.x.PubMedCrossRefGoogle Scholar
  38. 38.
    Puli SR, Reddy JB, Bechtold ML, Antillon MR, Brugge WR. EUS-guided celiac plexus neurolysis for pain due to chronic pancreatitis or pancreatic cancer pain: a meta-analysis and systematic review. Dig Dis Sci. 2009;54(11):2330–7. doi: 10.1007/s10620-008-0651-x.PubMedCrossRefGoogle Scholar
  39. 39.
    Kaufman M, Singh G, Das S, Concha-Parra R, Erber J, Micames C, et al. Efficacy of endoscopic ultrasound-guided celiac plexus block and celiac plexus neurolysis for managing abdominal pain associated with chronic pancreatitis and pancreatic cancer. J Clin Gastroenterol. 2010;44(2):127–34. doi: 10.1097/MCG.0b013e3181bb854d.PubMedCrossRefGoogle Scholar
  40. 40.
    Nagels W, Pease N, Bekkering G, Cools F, Dobbels P. Celiac plexus neurolysis for abdominal cancer pain: a systematic review. Pain Med. 2013;14(8):1140–63. doi: 10.1111/pme.12176.PubMedCrossRefGoogle Scholar
  41. 41.
    Wyse JM, Carone M, Paquin SC, Usatii M, Sahai AV. Randomized, double-blind, controlled trial of early endoscopic ultrasound-guided celiac plexus neurolysis to prevent pain progression in patients with newly diagnosed, painful, inoperable pancreatic cancer. J Clin Oncol Off J Am Soc Clin Oncol. 2011;29(26):3541–6. doi: 10.1200/jco.2010.32.2750.CrossRefGoogle Scholar
  42. 42.
    Levy MJ, Topazian MD, Wiersema MJ, Clain JE, Rajan E, Wang KK, et al. Initial evaluation of the efficacy and safety of endoscopic ultrasound-guided direct ganglia neurolysis and block. Am J Gastroenterol. 2008;103(1):98–103. doi: 10.1111/j.1572-0241.2007.01607.x.PubMedCrossRefGoogle Scholar
  43. 43.
    Ascunce G, Ribeiro A, Reis I, Rocha-Lima C, Sleeman D, Merchan J, et al. EUS visualization and direct celiac ganglia neurolysis predicts better pain relief in patients with pancreatic malignancy (with video). Gastrointest Endosc. 2011;73(2):267–74. doi: 10.1016/j.gie.2010.10.029.PubMedCrossRefGoogle Scholar
  44. 44.
    Doi S, Yasuda I, Kawakami H, Hayashi T, Hisai H, Irisawa A, et al. Endoscopic ultrasound-guided celiac ganglia neurolysis vs. celiac plexus neurolysis: a randomized multicenter trial. Endoscopy. 2013;45(5):362–9. doi: 10.1055/s-0032-1326225.PubMedCrossRefGoogle Scholar
  45. 45.
    Minaga K, Kitano M, Sakamoto H, Miyata T, Imai H, Yamao K, et al. Predictors of pain response in patients undergoing endoscopic ultrasound-guided neurolysis for abdominal pain caused by pancreatic cancer. Ther Adv Gastroenterol. 2016;9(4):483–94. doi: 10.1177/1756283x16644248.CrossRefGoogle Scholar
  46. 46.
    • Fujii-Lau LL, Bamlet WR, Eldrige JS, Chari ST, Gleeson FC, Abu Dayyeh BK, et al. Impact of celiac neurolysis on survival in patients with pancreatic cancer. Gastrointest Endosc. 2015;82(1):46–56 e2. doi: 10.1016/j.gie.2014.12.036. Retrospective study suggests that EUS-CPN is an independent predictor of shortened survival in pancreas cancer patients.PubMedCrossRefGoogle Scholar
  47. 47.
    Sahai AV, Lemelin V, Lam E, Paquin SC. Central vs. bilateral endoscopic ultrasound-guided celiac plexus block or neurolysis: a comparative study of short-term effectiveness. Am J Gastroenterol. 2009;104(2):326–9. doi: 10.1038/ajg.2008.64.PubMedCrossRefGoogle Scholar
  48. 48.
    LeBlanc JK, Al-Haddad M, McHenry L, Sherman S, Juan M, McGreevy K, et al. A prospective, randomized study of EUS-guided celiac plexus neurolysis for pancreatic cancer: one injection or two? Gastrointest Endosc. 2011;74(6):1300–7. doi: 10.1016/j.gie.2011.07.073.PubMedCrossRefGoogle Scholar
  49. 49.
    O'Toole TM, Schmulewitz N. Complication rates of EUS-guided celiac plexus blockade and neurolysis: results of a large case series. Endoscopy. 2009;41(7):593–7. doi: 10.1055/s-0029-1214868.PubMedCrossRefGoogle Scholar
  50. 50.
    Alvarez-Sanchez MV, Jenssen C, Faiss S, Napoleon B. Interventional endoscopic ultrasonography: an overview of safety and complications. Surg Endosc. 2014;28(3):712–34. doi: 10.1007/s00464-013-3260-5.PubMedCrossRefGoogle Scholar
  51. 51.
    Loeve US, Mortensen MB. Lethal necrosis and perforation of the stomach and the aorta after multiple EUS-guided celiac plexus neurolysis procedures in a patient with chronic pancreatitis. Gastrointest Endosc. 2013;77(1):151–2. doi: 10.1016/j.gie.2012.03.005.PubMedCrossRefGoogle Scholar
  52. 52.
    Jang HY, Cha SW, Lee BH, Jung HE, Choo JW, Cho YJ, et al. Hepatic and splenic infarction and bowel ischemia following endoscopic ultrasound-guided celiac plexus neurolysis. Clin Endosc. 2013;46(3):306–9. doi: 10.5946/ce.2013.46.3.306.PubMedPubMedCentralCrossRefGoogle Scholar
  53. 53.
    Gimeno-Garcia AZ, Elwassief A, Paquin SC, Sahai AV. Fatal complication after endoscopic ultrasound-guided celiac plexus neurolysis. Endoscopy. 2012;44(Suppl 2 UCTN):E267. doi: 10.1055/s-0032-1309709.PubMedGoogle Scholar
  54. 54.
    Fujii L, Clain JE, Morris JM, Levy MJ. Anterior spinal cord infarction with permanent paralysis following endoscopic ultrasound celiac plexus neurolysis. Endoscopy. 2012;44(Suppl 2 UCTN):E265–6. doi: 10.1055/s-0032-1309708.PubMedGoogle Scholar
  55. 55.
    Mittal MK, Rabinstein AA, Wijdicks EF. Pearls & oy-sters: acute spinal cord infarction following endoscopic ultrasound-guided celiac plexus neurolysis. Neurology. 2012;78(9):e57–9. doi: 10.1212/WNL.0b013e318248df51.PubMedCrossRefGoogle Scholar
  56. 56.
    Minaga K, Kitano M, Imai H, Miyata T, Kudo M. Acute spinal cord infarction after EUS-guided celiac plexus neurolysis. Gastrointest Endosc. 2016;83(5):1039–1040; discussion 40. doi: 10.1016/j.gie.2015.10.044.PubMedCrossRefGoogle Scholar
  57. 57.
    Mulhall AM, Rashkin MC, Pina EM. Bilateral diaphragmatic paralysis: a rare complication related to endoscopic ultrasound-guided celiac plexus neurolysis. Ann Am Thorac Soc. 2016;13(9):1660–2. doi: 10.1513/AnnalsATS.201603-190LE.PubMedCrossRefGoogle Scholar
  58. 58.
    Lalueza A, Lopez-Medrano F, del Palacio A, Alhambra A, Alvarez E, Ramos A, et al. Cladosporium macrocarpum brain abscess after endoscopic ultrasound-guided celiac plexus block. Endoscopy. 2011;43(Suppl 2 UCTN):E9–10. doi: 10.1055/s-0030-1255804.PubMedCrossRefGoogle Scholar
  59. 59.
    Johnson CD. Gastric outlet obstruction malignant until proved otherwise. Am J Gastroenterol. 1995;90(10):1740.PubMedGoogle Scholar
  60. 60.
    Shone DN, Nikoomanesh P, Smith-Meek MM, Bender JS. Malignancy is the most common cause of gastric outlet obstruction in the era of H2 blockers. Am J Gastroenterol. 1995;90(10):1769–70.PubMedGoogle Scholar
  61. 61.
    Chowdhury A, Dhali GK, Banerjee PK. Etiology of gastric outlet obstruction. Am J Gastroenterol. 1996;91(8):1679.PubMedGoogle Scholar
  62. 62.
    Dormann A, Meisner S, Verin N, Wenk LA. Self-expanding metal stents for gastroduodenal malignancies: systematic review of their clinical effectiveness. Endoscopy. 2004;36(6):543–50. doi: 10.1055/s-2004-814434.PubMedCrossRefGoogle Scholar
  63. 63.
    Fukami N, Anderson MA, Khan K, Harrison ME, Appalaneni V, Ben-Menachem T, et al. The role of endoscopy in gastroduodenal obstruction and gastroparesis. Gastrointest Endosc. 2011;74(1):13–21. doi: 10.1016/j.gie.2010.12.003.PubMedCrossRefGoogle Scholar
  64. 64.
    van Hooft JE, Dijkgraaf MG, Timmer R, Siersema PD, Fockens P. Independent predictors of survival in patients with incurable malignant gastric outlet obstruction: a multicenter prospective observational study. Scand J Gastroenterol. 2010;45(10):1217–22. doi: 10.3109/00365521.2010.487916.PubMedCrossRefGoogle Scholar
  65. 65.
    Jeurnink SM, Steyerberg EW, van Hooft JE, van Eijck CH, Schwartz MP, Vleggaar FP, et al. Surgical gastrojejunostomy or endoscopic stent placement for the palliation of malignant gastric outlet obstruction (SUSTENT study): a multicenter randomized trial. Gastrointest Endosc. 2010;71(3):490–9. doi: 10.1016/j.gie.2009.09.042.PubMedCrossRefGoogle Scholar
  66. 66.
    Woo SM, Kim DH, Lee WJ, Park KW, Park SJ, Han SS, et al. Comparison of uncovered and covered stents for the treatment of malignant duodenal obstruction caused by pancreaticobiliary cancer. Surg Endosc. 2013;27(6):2031–9. doi: 10.1007/s00464-012-2705-6.PubMedCrossRefGoogle Scholar
  67. 67.
    van den Berg MW, Walter D, Vleggaar FP, Siersema PD, Fockens P, van Hooft JE. High proximal migration rate of a partially covered “big cup” duodenal stent in patients with malignant gastric outlet obstruction. Endoscopy. 2014;46(2):158–61. doi: 10.1055/s-0033-1359023.PubMedGoogle Scholar
  68. 68.
    Jeurnink SM, Repici A, Luigiano C, Pagano N, Kuipers EJ, Siersema PD. Use of a colonoscope for distal duodenal stent placement in patients with malignant obstruction. Surg Endosc. 2009;23(3):562–7. doi: 10.1007/s00464-008-9880-5.PubMedCrossRefGoogle Scholar
  69. 69.
    Mauro MA, Koehler RE, Baron TH. Advances in gastrointestinal intervention: the treatment of gastroduodenal and colorectal obstructions with metallic stents. Radiology. 2000;215(3):659–69. doi: 10.1148/radiology.215.3.r00jn30659.PubMedCrossRefGoogle Scholar
  70. 70.
    Kochar R, Shah N. Enteral stents: from esophagus to colon. Gastrointest Endosc. 2013;78(6):913–8. doi: 10.1016/j.gie.2013.07.015.PubMedCrossRefGoogle Scholar
  71. 71.
    Boskoski I, Tringali A, Familiari P, Mutignani M, Costamagna G. Self-expandable metallic stents for malignant gastric outlet obstruction. Adv Ther. 2010;27(10):691–703. doi: 10.1007/s12325-010-0061-2.PubMedCrossRefGoogle Scholar
  72. 72.
    Adler DG, Baron TH. Endoscopic palliation of malignant gastric outlet obstruction using self-expanding metal stents: experience in 36 patients. Am J Gastroenterol. 2002;97(1):72–8. doi: 10.1111/j.1572-0241.2002.05423.x.PubMedCrossRefGoogle Scholar
  73. 73.
    van Hooft JE, Uitdehaag MJ, Bruno MJ, Timmer R, Siersema PD, Dijkgraaf MG, et al. Efficacy and safety of the new WallFlex enteral stent in palliative treatment of malignant gastric outlet obstruction (DUOFLEX study): a prospective multicenter study. Gastrointest Endosc. 2009;69(6):1059–66. doi: 10.1016/j.gie.2008.07.026.PubMedCrossRefGoogle Scholar
  74. 74.
    Piesman M, Kozarek RA, Brandabur JJ, Pleskow DK, Chuttani R, Eysselein VE, et al. Improved oral intake after palliative duodenal stenting for malignant obstruction: a prospective multicenter clinical trial. Am J Gastroenterol. 2009;104(10):2404–11. doi: 10.1038/ajg.2009.409.PubMedCrossRefGoogle Scholar
  75. 75.
    Graber I, Dumas R, Filoche B, Boyer J, Coumaros D, Lamouliatte H, et al. The efficacy and safety of duodenal stenting: a prospective multicenter study. Endoscopy. 2007;39(9):784–7. doi: 10.1055/s-2007-966594.PubMedCrossRefGoogle Scholar
  76. 76.
    Kim JH, Song HY, Shin JH, Choi E, Kim TW, Jung HY, et al. Metallic stent placement in the palliative treatment of malignant gastroduodenal obstructions: prospective evaluation of results and factors influencing outcome in 213 patients. Gastrointest Endosc. 2007;66(2):256–64. doi: 10.1016/j.gie.2006.12.017.PubMedCrossRefGoogle Scholar
  77. 77.
    Lowe AS, Beckett CG, Jowett S, May J, Stephenson S, Scally A, et al. Self-expandable metal stent placement for the palliation of malignant gastroduodenal obstruction: experience in a large, single. UK Cent Clin Radiol. 2007;62(8):738–44. doi: 10.1016/j.crad.2007.01.021.CrossRefGoogle Scholar
  78. 78.
    Havemann MC, Adamsen S, Wojdemann M. Malignant gastric outlet obstruction managed by endoscopic stenting: a prospective single-centre study. Scand J Gastroenterol. 2009;44(2):248–51. doi: 10.1080/00365520802530820.PubMedCrossRefGoogle Scholar
  79. 79.
    Kim CG, Choi IJ, Lee JY, Cho SJ, Park SR, Lee JH, et al. Covered versus uncovered self-expandable metallic stents for palliation of malignant pyloric obstruction in gastric cancer patients: a randomized, prospective study. Gastrointest Endosc. 2010;72(1):25–32. doi: 10.1016/j.gie.2010.01.039.PubMedCrossRefGoogle Scholar
  80. 80.
    Khashab M, Alawad AS, Shin EJ, Kim K, Bourdel N, Singh VK, et al. Enteral stenting versus gastrojejunostomy for palliation of malignant gastric outlet obstruction. Surg Endosc. 2013;27(6):2068–75. doi: 10.1007/s00464-012-2712-7.PubMedCrossRefGoogle Scholar
  81. 81.
    Shaw JM, Bornman PC, Krige JE, Stupart DA, Panieri E. Self-expanding metal stents as an alternative to surgical bypass for malignant gastric outlet obstruction. Br J Surg. 2010;97(6):872–6. doi: 10.1002/bjs.6968.PubMedCrossRefGoogle Scholar
  82. 82.
    • Tringali A, Didden P, Repici A, Spaander M, Bourke MJ, Williams SJ, et al. Endoscopic treatment of malignant gastric and duodenal strictures: a prospective, multicenter study. Gastrointest Endosc. 2014;79(1):66–75. doi: 10.1016/j.gie.2013.06.032. The article highlights the impact of enteral stent placement in which the technical success was 99% and stent patency was high at one month but tapers off by 6 months which furthermore confirms the need to stratify who gets stentign vs surgery as primary treatment for GOO based on life expectancy.PubMedCrossRefGoogle Scholar
  83. 83.
    •• Nagaraja V, Eslick GD, Cox MR. Endoscopic stenting versus operative gastrojejunostomy for malignant gastric outlet obstruction-a systematic review and meta-analysis of randomized and non-randomized trials. J Gastrointest Oncol. 2014;5(2):92–8. doi: 10.3978/j.issn.2078-6891.2014.016. This article highlights that endoscopic stent placement is associated with better short-term outcomes with regards to resuming oral intake, hospital stay, and similar complication rates. Recent systemic review evaluating endoscopic stenting versus operative gastrojejunostomy for GOO. Patient treated with SEMS has shorter time to tolerating oral diet and shorter hospital stay.PubMedPubMedCentralGoogle Scholar
  84. 84.
    Jeurnink SM, Steyerberg EW, Hof G, van Eijck CH, Kuipers EJ, Siersema PD. Gastrojejunostomy versus stent placement in patients with malignant gastric outlet obstruction: a comparison in 95 patients. J Surg Oncol. 2007;96(5):389–96. doi: 10.1002/jso.20828.PubMedCrossRefGoogle Scholar
  85. 85.
    No JH, Kim SW, Lim CH, Kim JS, Cho YK, Park JM, et al. Long-term outcome of palliative therapy for gastric outlet obstruction caused by unresectable gastric cancer in patients with good performance status: endoscopic stenting versus surgery. Gastrointest Endosc. 2013;78(1):55–62. doi: 10.1016/j.gie.2013.01.041.PubMedCrossRefGoogle Scholar
  86. 86.
    Jeurnink SM, van Eijck CH, Steyerberg EW, Kuipers EJ, Siersema PD. Stent versus gastrojejunostomy for the palliation of gastric outlet obstruction: a systematic review. BMC Gastroenterol. 2007;7:18. doi: 10.1186/1471-230x-7-18.PubMedPubMedCentralCrossRefGoogle Scholar
  87. 87.
    Roy A, Kim M, Christein J, Varadarajulu S. Stenting versus gastrojejunostomy for management of malignant gastric outlet obstruction: comparison of clinical outcomes and costs. Surg Endosc. 2012;26(11):3114–9. doi: 10.1007/s00464-012-2301-9.PubMedPubMedCentralCrossRefGoogle Scholar
  88. 88.
    Mendelsohn RB, Gerdes H, Markowitz AJ, DiMaio CJ, Schattner MA. Carcinomatosis is not a contraindication to enteral stenting in selected patients with malignant gastric outlet obstruction. Gastrointest Endosc. 2011;73(6):1135–40. doi: 10.1016/j.gie.2011.01.042.PubMedCrossRefGoogle Scholar
  89. 89.
    Fukami N, Bults A, El Hajj I, Amateau SK, Wani S, Brauer BC, et al. Sa1601 underwater EMR for colorectal lesions: a prospective study on efficacy and safety. Gastrointest Endosc. 2014;79(5):AB270. doi: 10.1016/j.gie.2014.05.219.CrossRefGoogle Scholar
  90. 90.
    Park JC, Park JJ, Cheoi K, Chung H, Lee H, Shin SK, et al. Clinical outcomes of secondary stent-in-stent self-expanding metal stent placement for primary stent malfunction in malignant gastric outlet obstruction. Dig Liver Dis. 2012;44(12):999–1005. doi: 10.1016/j.dld.2012.06.019.PubMedCrossRefGoogle Scholar
  91. 91.
    Mutignani M, Tringali A, Shah SG, Perri V, Familiari P, Iacopini F, et al. Combined endoscopic stent insertion in malignant biliary and duodenal obstruction. Endoscopy. 2007;39(5):440–7. doi: 10.1055/s-2007-966327.PubMedCrossRefGoogle Scholar
  92. 92.
    Topazian M, Baron TH. Endoscopic fenestration of duodenal stents using argon plasma to facilitate ERCP. Gastrointest Endosc. 2009;69(1):166–9. doi: 10.1016/j.gie.2008.08.026.PubMedCrossRefGoogle Scholar
  93. 93.
    Kahaleh M, Hernandez AJ, Tokar J, Adams RB, Shami VM, Yeaton P. Interventional EUS-guided cholangiography: evaluation of a technique in evolution. Gastrointest Endosc. 2006;64(1):52–9. doi: 10.1016/j.gie.2006.01.063.PubMedCrossRefGoogle Scholar
  94. 94.
    Khashab MA, Messallam AA, Penas I, Nakai Y, Modayil RJ, De la Serna C, et al. International multicenter comparative trial of transluminal EUS-guided biliary drainage via hepatogastrostomy vs. choledochoduodenostomy approaches. Endosc Int Open. 2016;4(2):E175–81. doi: 10.1055/s-0041-109083.PubMedPubMedCentralCrossRefGoogle Scholar
  95. 95.
    •• Khashab MA, Kumbhari V, Grimm IS, Ngamruengphong S, Aguila G, El Zein M, et al. EUS-guided gastroenterostomy: the first U.S. clinical experience (with video). Gastrointest Endosc. 2015;82(5):932–8. doi: 10.1016/j.gie.2015.06.017. First US clinic experience for EUS-guided gastroenterostomy as an alternative method for palliation of GOO. This study may be ground breaking if further studies confirm the effectiveness of this endoscopic approach and may potentially replace surgical GJ long term.PubMedCrossRefGoogle Scholar
  96. 96.
    Barthet M, Binmoeller KF, Vanbiervliet G, Gonzalez JM, Baron TH, Berdah S. Natural orifice transluminal endoscopic surgery gastroenterostomy with a biflanged lumen-apposing stent: first clinical experience (with videos). Gastrointest Endosc. 2015;81(1):215–8. doi: 10.1016/j.gie.2014.09.039.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2017

Authors and Affiliations

  1. 1.Gastrointestinal Tumor Program, Section of Endoscopic OncologyMoffitt Cancer CenterTampaUSA

Personalised recommendations